ADIPOQ and Hepatic fibrosis: In this study, we established the experimental liver injury models with TAA, and the administration of ADP355 was performed to examine whether ADP355 functions with adiponectin-like action against inflammation and liver fibrosis and attenuated the enhancement of liver fibrosis in adipo(−/−) mice.